Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 05; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program.

  • Authors : Lewis KA; Department of Physiological Nursing, School of Nursing, University of California, 2 Koret Way, San Francisco, CA 94143, USA.; Stroebel BM

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Metformin*/Metformin*/Metformin*/pharmacology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 23; Vol. 25 (11). Date of Electronic Publication: 2024 May 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.

  • Authors : Plowman TJ; Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT 84606, USA.; Christensen H

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Metformin*/Metformin*/Metformin*/pharmacology ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 10; Vol. 25 (10). Date of Electronic Publication: 2024 May 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Profiling the Antidiabetic Potential of Compounds Identified from Fractionated Extracts of Entada africana toward Glucokinase Stimulation: Computational Insight.

  • Authors : Onikanni SA; College of Medicine, Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.; Department of Chemical Sciences, Biochemistry Unit, Afe-Babalola University, Ado-Ekiti 360101, Ekiti State, Nigeria.

Subjects: Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/pharmacology ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Molecules (Basel, Switzerland) [Molecules] 2023 Jul 30; Vol. 28 (15). Date of Electronic Publication: 2023 Jul 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Synthesis and Evaluation of Hypoglycemic Activity of Structural Isomers of ((Benzyloxy)phenyl)propanoic Acid Bearing an Aminobornyl Moiety.

  • Authors : Kuranov SO; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.; Pon Kina DA

Subjects: Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/chemistry ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Mice

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 28; Vol. 24 (9). Date of Electronic Publication: 2023 Apr 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression.

  • Authors : Arefin A; Wolfson Institute for Biomedical Research, Division of Medicine, University College London, Gower Street, London WC1E 6BT, UK.; Gage MC

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/pharmacology ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 01; Vol. 24 (5). Date of Electronic Publication: 2023 Mar 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes.

  • Authors : Li Y; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.; Hu H

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use ; Social Determinants of Health*

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2023 Feb 24; Vol. 20 (5). Date of Electronic Publication: 2023 Feb 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes.

  • Authors : Ji X; School of Exercise and Health, Shanghai University of Sport, Shanghai 200433, China.; Zhang W

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; PPAR gamma*/PPAR gamma*/PPAR gamma*/metabolism

  • Source: Biomolecules [Biomolecules] 2022 Dec 08; Vol. 12 (12). Date of Electronic Publication: 2022 Dec 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-10 of  315 نتائج ل ""Diabetes Mellitus, Type 2""